Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Medicenna Therapeutics Corp. (MDNAF) had Weighted-Average Shares Outstanding (Diluted) of 76.67M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$0.93M |
|
-- |
|
-- |
|
$4.01M |
|
$-4.01M |
|
$4.94M |
|
$0.93M |
|
$0.93M |
|
$0.93M |
|
$0.93M |
|
$0.93M |
|
$0.93M |
|
$-4.01M |
|
$-3.99M |
|
76.67M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
76.67M |
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$20.25M |
|
$0.01M |
|
$0.15M |
|
$20.40M |
|
$3.19M |
|
-- |
|
$3.49M |
|
$6.67M |
|
$13.72M |
|
$13.69M |
|
$13.72M |
|
78.22M |
|
| Cash Flow Statement Financials | |
$-11.85M |
|
$-0.02M |
|
$16.88M |
|
$12.21M |
|
$17.85M |
|
$5.65M |
|
$1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
6.80% |
|
6.82% |
|
4.57% |
|
6.80% |
|
$0.18 |
|
$-0.15 |
|
$-0.15 |
|